Mackenzie Financial Corp trimmed its holdings in Equifax, Inc. (NYSE:EFX - Free Report) by 20.2% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 156,957 shares of the credit services provider's stock after selling 39,791 shares during the period. Mackenzie Financial Corp owned 0.13% of Equifax worth $38,228,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD boosted its holdings in shares of Equifax by 15.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,027,817 shares of the credit services provider's stock worth $1,281,340,000 after buying an additional 679,688 shares during the period. Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of Equifax by 0.4% in the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 3,123,701 shares of the credit services provider's stock worth $796,075,000 after purchasing an additional 11,861 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Equifax by 2.5% in the 4th quarter. Geode Capital Management LLC now owns 2,957,204 shares of the credit services provider's stock worth $751,645,000 after purchasing an additional 71,543 shares during the last quarter. Northern Trust Corp grew its holdings in Equifax by 10.7% during the 4th quarter. Northern Trust Corp now owns 1,207,225 shares of the credit services provider's stock worth $307,661,000 after acquiring an additional 116,524 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in shares of Equifax by 4.4% in the 1st quarter. Bank of New York Mellon Corp now owns 1,098,718 shares of the credit services provider's stock valued at $267,604,000 after purchasing an additional 46,505 shares during the last quarter. 96.20% of the stock is owned by institutional investors.
Equifax Stock Down 0.3%
Shares of NYSE:EFX traded down $0.62 during midday trading on Friday, hitting $239.61. The stock had a trading volume of 1,606,211 shares, compared to its average volume of 1,057,958. Equifax, Inc. has a 12 month low of $199.98 and a 12 month high of $309.63. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.79. The business's 50-day simple moving average is $259.11 and its 200-day simple moving average is $252.97. The company has a market cap of $29.66 billion, a P/E ratio of 46.89, a PEG ratio of 2.68 and a beta of 1.60.
Equifax (NYSE:EFX - Get Free Report) last released its earnings results on Tuesday, July 22nd. The credit services provider reported $2.00 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.08. Equifax had a net margin of 10.95% and a return on equity of 18.89%. The business had revenue of $1.54 billion during the quarter, compared to analysts' expectations of $1.51 billion. During the same period last year, the business earned $1.82 earnings per share. The firm's revenue was up 7.4% on a year-over-year basis. On average, sell-side analysts forecast that Equifax, Inc. will post 7.58 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on EFX. Oppenheimer cut their price target on shares of Equifax from $296.00 to $279.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 23rd. Wells Fargo & Company cut their price target on shares of Equifax from $310.00 to $300.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 23rd. Stifel Nicolaus increased their price target on shares of Equifax from $277.00 to $295.00 and gave the company a "buy" rating in a research report on Wednesday, June 18th. Bank of America downgraded shares of Equifax from a "buy" rating to a "neutral" rating and cut their price target for the company from $300.00 to $285.00 in a research report on Monday, June 23rd. Finally, Morgan Stanley reiterated an "overweight" rating and issued a $305.00 price target (up from $295.00) on shares of Equifax in a research report on Tuesday, June 10th. Seven research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $285.00.
Check Out Our Latest Research Report on EFX
Insiders Place Their Bets
In related news, CEO Mark W. Begor sold 48,264 shares of the business's stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $241.71, for a total value of $11,665,891.44. Following the completion of the transaction, the chief executive officer owned 142,872 shares of the company's stock, valued at $34,533,591.12. The trade was a 25.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP John W. Gamble, Jr. sold 2,000 shares of the business's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $259.10, for a total value of $518,200.00. Following the transaction, the executive vice president directly owned 65,176 shares of the company's stock, valued at approximately $16,887,101.60. The trade was a 2.98% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.40% of the company's stock.
Equifax Profile
(
Free Report)
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Featured Stories

Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report